Nine Ten Capital Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $33.9M | Buy |
2,121,534
+122,500
| +6% | +$1.96M | 10.1% | 5 |
|
2025
Q1 | $38.8M | Sell |
1,999,034
-1,606,570
| -45% | -$31.2M | 14.5% | 3 |
|
2024
Q4 | $79.4M | Sell |
3,605,604
-721,194
| -17% | -$15.9M | 22.67% | 1 |
|
2024
Q3 | $72.9M | Buy |
4,326,798
+403,086
| +10% | +$6.79M | 22.02% | 1 |
|
2024
Q2 | $46.9M | Buy |
3,923,712
+452,514
| +13% | +$5.41M | 18.05% | 1 |
|
2024
Q1 | $38.5M | Sell |
3,471,198
-235,000
| -6% | -$2.6M | 11.71% | 4 |
|
2023
Q4 | $32.1M | Buy |
3,706,198
+2,639,596
| +247% | +$22.9M | 8.07% | 6 |
|
2023
Q3 | $8.16M | Buy |
1,066,602
+651,634
| +157% | +$4.99M | 2.49% | 10 |
|
2023
Q2 | $2.99M | Buy |
+414,968
| New | +$2.99M | 1% | 8 |
|